Rare Disease Report

Alexion's Criteria for Drug Development in Severe, Devastating Diseases

NOVEMBER 14, 2014


In this exclusive interview with Rare Disease Report, Martin Mackay, PHD, global head of research and development at Alexion Pharmaceuticals, talks about how the company decides which rare disease to investigate.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
$related$
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.